Phosphatidylcholine: Mechanism of Action and Potential Side Effects

Phosphatidylcholine, commonly referred to as lecithin, represents one of the most critical phospholipids—a class of complex lipid compounds structurally composed of glycerol, long-chain fatty acids, a phosphoric acid moiety, and choline. These biologically active molecules play indispensable roles within the human body, with particularly high concentrations observed in metabolically active tissues such as neural structures, the liver, and blood, where they fulfill structural, energetic, and regulatory functions. Of paramount importance is phosphatidylcholine’s role as an essential constituent of all cellular membranes, where it ensures fluidity, selective permeability, and structural integrity—factors that are fundamental to proper cellular operation. Beyond its structural contributions, this phospholipid serves as a vital energy substrate, bolstering immune system defenses and actively participating in tissue regeneration processes, most notably within the liver, where it governs the synthesis, transportation, and storage of lipids, including cholesterol. Emerging scientific research continues to elucidate the therapeutic and preventive potential of phospholipids, particularly in mitigating risks associated with metabolic disorders, neurodegenerative diseases, and cardiovascular conditions. The most nutrient-dense dietary sources of phosphatidylcholine include chicken egg yolks, beef liver, soy-based products (such as soy oil), peanuts, wheat germ, oatmeal, and green vegetables like asparagus. For individuals with elevated requirements or deficiencies, high-quality pharmaceutical formulations are also available, providing precisely calibrated doses of this phospholipid—often in conjunction with other bioactive compounds that enhance its absorption and metabolic utilization.

It is essential to emphasize the pivotal role that phospholipids play in both the prevention and therapeutic management of disorders affecting such a vital organ as the liver, as well as the gallbladder. These bioactive compounds are of paramount importance even in the initial phases of hepatic disease treatment, as they effectively inhibit the progression of fibrotic tissue remodeling while concurrently enhancing cholesterol solubility within bile, thereby substantially reducing the risk of gallstone formation in the biliary tract. A consistent dietary intake of phospholipids constitutes a critical preventive measure against hepatic steatosis—a condition closely associated with chronic alcohol abuse and the consumption of an imbalanced diet rich in detrimental saturated fatty acids, *trans* fatty acid isomers, and pro-inflammatory simple carbohydrates. Furthermore, phospholipids are integral structural components of plasma lipoproteins (including LDL, HDL, VLDL, and IDL fractions), where they regulate the processes of synthesis, transport, and metabolic turnover, thereby ensuring the maintenance of lipid homeostasis. Phosphatidylcholine, accounting for up to 40% of the total phospholipid content in biological membranes, forms what is known as the *„fluid mosaic“*—a dynamic lipid-protein matrix in which both membrane-bound proteins and functional lipids are embedded. Its high concentration directly optimizes membrane properties such as elasticity, fluidity, and selective permeability, while also preserving the proper functionality of membrane receptors and signaling proteins, which are indispensable for efficient intercellular communication and substance transport. Additionally, phosphatidylcholine exerts a beneficial effect on the digestive and respiratory systems by contributing to the formation of a protective surfactant layer on epithelial surfaces. This compound also enhances the bioavailability of fat-soluble vitamins (A, D, E, K) and demonstrates a well-documented antiatherogenic effect, which involves the modulation of molecular concentrations implicated in the pathogenesis of atherosclerotic plaques. This mechanism further includes the emulsification of lipids—i.e., the breakdown of fat globules into smaller micelles—to facilitate their metabolic processing. Through the properties of phospholipids, it is also possible to inhibit cholesterol accumulation within the vascular endothelium, as they improve hemorheological parameters (by reducing platelet aggregation), increase erythrocyte flexibility, and promote microcirculatory flow.

Phosphatidylcholine, a naturally occurring phospholipid present in numerous dietary sources, is generally regarded as safe when consumed as part of a balanced diet. However, excessive intake of choline—a critical structural component embedded within the phosphatidylcholine molecule—may elicit adverse physiological responses. In the United States, regulatory guidelines have established an upper tolerable intake level for choline at 3.5 grams per day, a threshold that must not be exceeded under any circumstances. Under normal physiological conditions, choline is absorbed within the small intestine; yet when consumed in surplus quantities that exceed absorptive capacity, the unabsorbed fraction translocates to the large intestine. There, it undergoes microbial conversion into trimethylamine (TMA), which, upon systemic absorption, is further metabolized in the liver to form trimethylamine N-oxide (TMAO)—a metabolite whose elevated serum concentrations have been epidemiologically linked to an increased risk of cardiovascular disease development. Beyond this, scientific literature documents additional potential consequences of choline overconsumption, including hypotension, gastrointestinal disturbances (such as diarrhea and abdominal distension), hyperhidrosis, and episodic nausea. Notwithstanding these risks, phosphatidylcholine fulfills vital biological roles: it modulates cellular membrane fluidity, exerts hepatoprotective effects by mitigating the progression of liver pathology, and supports vascular integrity by inhibiting the formation of atherosclerotic plaques that could otherwise impede arterial blood flow.